PRNewsWire - Health - Latest News Search Engine - Global and Local Breaking News

PRNewsWire - Health

Indivior Announces FDA Approval of Label Changes for SUBLOCADE® (buprenorphine extended-release) Injection

Rapid Initiation Protocol Reduces Time to Treatment with SUBLOCADE® From One Week to One Hour, A Significant Advancement in the Treatment of Moderate ...

Indivior Announces FDA Approval of Label Changes for SUBLOCADE® (buprenorphine extended-release) Injection

MGI Tech Closes Strategic Partnership with Oncoclínicas&Co to Contribute to Genomic Innovation in Oncological Health

Agreement contributes to expanding access to cutting-edge genomic technologies and improving diagnostic efficacy SÃO PAULO, Feb. 23, 2025 /PRNewswire/...

MGI Tech Closes Strategic Partnership with Oncoclínicas&Co to Contribute to Genomic Innovation in Oncological Health

Fangzhou Inc. Announces Inclusion as a Constituent of the Hang Seng Composite Index

HONG KONG, Feb. 23, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, announced ...

NMPA Accepts NDA and Grants Priority Review Designation to Innovent's Ipilimumab Injection, China's First Domestic CTLA-4 Inhibitor, in Combination wi...

SAN FRANCISCO and SUZHOU, China, Feb. 23, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical co...

NMPA Accepts NDA and Grants Priority Review Designation to Innovent's Ipilimumab Injection, China's First Domestic CTLA-4 Inhibitor, in Combination with Sintilimab as Neoadjuvant Treatment for Colon Cancer